Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.
It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
House Speaker Nancy Pelosi, D-Calif., on Tuesday commended Tanazanian President Jakaya Kikwete on the country's utilization of U.S. aid money and vowed her support for the country's future development projects, during a meeting in Washington, D.C., the Zimbabwean reports. "Pelosi hailed President Kikwete and his government for the commitment demonstrated by the campaigns against HIV/AIDS, malaria and TB and implementation of MCC programmes," the newspaper writes (Kulekana, 9/30).
BioCryst Pharmaceuticals, Inc. today announced that it has delivered a written response to the request for proposal (RFP) announced on September 21, 2009 from the U.S. Department of Health & Human Services (HHS) for the supply of intravenous (i.v) peramivir for the treatment of critically ill influenza patients under Emergency Use Authorization (EUA). BioCryst management intends to provide an update once the RFP process has reached a conclusion.
As millions of Massachusetts children and teenagers returned to school this month, at the start of a serious flu season, the Northeast Homeland Security Regional Advisory Council (NERAC) has an important health message: "It's Up to You to Stop the Flu."
The latest H1N1 genomic data shows a 50% drop in the Replikin CountTM of the virus’s replikins lethality gene since its recorded highs in April 2009. In contrast, the Replikin Count of the virus’s infectivity gene showed a continued elevation.
As the battle against the H1N1 influenza outbreak continues, hospitals are on the front lines, charged with identifying, treating, monitoring, and reporting flu cases—as well as preventing their spread to other patients and hospital personnel. To facilitate this arduous task, a growing number of U.S. hospitals are using a patient safety surveillance system developed by TheraDoc that helps them more effectively coordinate their responses to this serious public health threat.
Aphios Corporation today announced that it has been awarded a RC-1 Challenge grant (No. 1RC1HL102822-01) from the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Health’s (NIH) American Recovery and Reinvestment Act (ARRA) funds to develop a generally-applicable pathogen inactivation technology for blood products.
ANXeBusiness Corp., a leading provider of networking and security managed services, today issued advice for IT organizations on the importance of disaster plan readiness, proper employee education and preparation for organizations to maintain business continuity during the H1N1 influenza pandemic.
The issuer's China based operating subsidiary Mellow Hope through its exclusive business partner Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd has been granted H1N1 license on September 24, 2009 by SFDA (China Authority) http://eng.sfda.gov.cn/eng. Mellow Hope is the exclusive agent of Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd for International marketing and sales.
Earthquakes, fires, floods, pandemics. The public relies on health professionals, emergency responders and trained volunteers to react appropriately to a range of disasters, big or small. But does everyone understand the systems that are in place to respond to these dreaded events?
Weill Cornell Medical College in Qatar hosted a detailed talk about a virus that's causing concern around the world. The recent cause of an interruption in local school openings, H1N1 information was presented in timely fashion by Dr. Abdullatif Al-Khal, head of the communicable disease unit at Hamad Medical Corporation, and Dr. Ravinder Mamtani, Professor of Public Health at WCMC-Q.
VeriChip Corporation ("VeriChip" or the "Company") today announced it has entered into a definitive agreement for a $10,000,000 investment commitment with Optimus Technology Capital Partners, LLC, or Optimus.
Research led by Dr. Jay Kolls, Professor and Chairman of Genetics at LSU Health Sciences Center New Orleans, has identified a therapeutic target for acute lung injury resulting in acute respiratory distress syndrome, a highly fatal complication of influenza infection.
A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study. The study, available online today in Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, found that fewer than 10 percent of those surveyed said they would be willing to take such a vaccine or drug and nearly 30 percent remained undecided.
Omaha-based Total Wellness, a leading provider of corporate health and wellness services, encourages employers – both large and small – to follow recommendations made by the Center for Disease Control and Prevention (CDC), which encourages employees to receive flu shots this fall.
Aetna announced today that it will provide first-dollar coverage for the administration of the H1N1 flu vaccine for all of its fully-insured health plan members, and for all members of self-funded plans unless directed otherwise by the plan sponsor. Aetna is offering this coverage even in instances where members’ plans do not include coverage for preventive care or have limits on such coverage.
UofT researchers have used nanomaterials to develop a microchip sensitive enough to quickly determine the type and severity of a patient's cancer so that the disease can be detected earlier for more effective treatment.
Ecolab Inc. continued its commitment to proactively help improve global food safety by co-sponsoring the fourth annual Nation's Restaurant News' Food Safety Symposium.
Hygafem, Inc., the Georgia-based premier provider of touch-free workplace wellness technologies and services, has successfully launched its hand sanitizing program at Morehouse College in Atlanta, GA. Hygafem’s touch-free hand sanitizing program decreases the risk of spreading disease, ensures safe and healthy facilities, and boosts satisfaction for students and employees at Morehouse College.
BDI Pharma, Inc., the fastest growing national wholesale distributor of biotech therapies, announced today the success of its proprietary supply program SecuriFLU. The program provides ordering solutions for customers who require quick, easy access to online ordering for flu vaccine. Customers may access brands from multiple manufacturers offering a full range of age indications.
According to George Kappler, "If hospitals were subjected to the same protection standards as factories, many would have been shut down a long time ago." Those are tough words for healthcare workers to hear as they brace for an onslaught of H1N1 patients, but the CEO of Kappler, Inc., a 33-year veteran in the protective garment business, knows of what he speaks.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.